Global Ocular Inflammation Treatment Market Research Report 2023

Report ID: 1983852 | Published Date: Jan 2025 | No. of Page: 85 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Ocular Inflammation Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Immunosuppressant
        1.2.3 Monoclonal Antibodies
        1.2.4 Corticosteroids
        1.2.5 Cycloplegic Agents
        1.2.6 Antibiotics
        1.2.7 Analgesics
        1.2.8 Antivirals
        1.2.9 Antifungal
    1.3 Market by Application
        1.3.1 Global Ocular Inflammation Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Retail Pharmacies
        1.3.3 Hospital Pharmacies
        1.3.4 Online Pharmacies
        1.3.5 Drug Stores
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Ocular Inflammation Treatment Market Perspective (2017-2028)
    2.2 Ocular Inflammation Treatment Growth Trends by Region
        2.2.1 Ocular Inflammation Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Ocular Inflammation Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Ocular Inflammation Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Ocular Inflammation Treatment Market Dynamics
        2.3.1 Ocular Inflammation Treatment Industry Trends
        2.3.2 Ocular Inflammation Treatment Market Drivers
        2.3.3 Ocular Inflammation Treatment Market Challenges
        2.3.4 Ocular Inflammation Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Ocular Inflammation Treatment Players by Revenue
        3.1.1 Global Top Ocular Inflammation Treatment Players by Revenue (2017-2022)
        3.1.2 Global Ocular Inflammation Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Ocular Inflammation Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Ocular Inflammation Treatment Revenue
    3.4 Global Ocular Inflammation Treatment Market Concentration Ratio
        3.4.1 Global Ocular Inflammation Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Ocular Inflammation Treatment Revenue in 2021
    3.5 Ocular Inflammation Treatment Key Players Head office and Area Served
    3.6 Key Players Ocular Inflammation Treatment Product Solution and Service
    3.7 Date of Enter into Ocular Inflammation Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Ocular Inflammation Treatment Breakdown Data by Type
    4.1 Global Ocular Inflammation Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Ocular Inflammation Treatment Forecasted Market Size by Type (2023-2028)
5 Ocular Inflammation Treatment Breakdown Data by Application
    5.1 Global Ocular Inflammation Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Ocular Inflammation Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Ocular Inflammation Treatment Market Size (2017-2028)
    6.2 North America Ocular Inflammation Treatment Market Size by Country (2017-2022)
    6.3 North America Ocular Inflammation Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Ocular Inflammation Treatment Market Size (2017-2028)
    7.2 Europe Ocular Inflammation Treatment Market Size by Country (2017-2022)
    7.3 Europe Ocular Inflammation Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Ocular Inflammation Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Ocular Inflammation Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Ocular Inflammation Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Ocular Inflammation Treatment Market Size (2017-2028)
    9.2 Latin America Ocular Inflammation Treatment Market Size by Country (2017-2022)
    9.3 Latin America Ocular Inflammation Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Ocular Inflammation Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Ocular Inflammation Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Ocular Inflammation Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Allergan
        11.1.1 Allergan Company Detail
        11.1.2 Allergan Business Overview
        11.1.3 Allergan Ocular Inflammation Treatment Introduction
        11.1.4 Allergan Revenue in Ocular Inflammation Treatment Business (2017-2022)
        11.1.5 Allergan Recent Development
    11.2 Cipla
        11.2.1 Cipla Company Detail
        11.2.2 Cipla Business Overview
        11.2.3 Cipla Ocular Inflammation Treatment Introduction
        11.2.4 Cipla Revenue in Ocular Inflammation Treatment Business (2017-2022)
        11.2.5 Cipla Recent Development
    11.3 Pfizer
        11.3.1 Pfizer Company Detail
        11.3.2 Pfizer Business Overview
        11.3.3 Pfizer Ocular Inflammation Treatment Introduction
        11.3.4 Pfizer Revenue in Ocular Inflammation Treatment Business (2017-2022)
        11.3.5 Pfizer Recent Development
    11.4 Novartis
        11.4.1 Novartis Company Detail
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Ocular Inflammation Treatment Introduction
        11.4.4 Novartis Revenue in Ocular Inflammation Treatment Business (2017-2022)
        11.4.5 Novartis Recent Development
    11.5 Valeant Pharmaceuticals International
        11.5.1 Valeant Pharmaceuticals International Company Detail
        11.5.2 Valeant Pharmaceuticals International Business Overview
        11.5.3 Valeant Pharmaceuticals International Ocular Inflammation Treatment Introduction
        11.5.4 Valeant Pharmaceuticals International Revenue in Ocular Inflammation Treatment Business (2017-2022)
        11.5.5 Valeant Pharmaceuticals International Recent Development
    11.6 Alimera Sciences
        11.6.1 Alimera Sciences Company Detail
        11.6.2 Alimera Sciences Business Overview
        11.6.3 Alimera Sciences Ocular Inflammation Treatment Introduction
        11.6.4 Alimera Sciences Revenue in Ocular Inflammation Treatment Business (2017-2022)
        11.6.5 Alimera Sciences Recent Development
    11.7 Akorn
        11.7.1 Akorn Company Detail
        11.7.2 Akorn Business Overview
        11.7.3 Akorn Ocular Inflammation Treatment Introduction
        11.7.4 Akorn Revenue in Ocular Inflammation Treatment Business (2017-2022)
        11.7.5 Akorn Recent Development
    11.8 Abbvie
        11.8.1 Abbvie Company Detail
        11.8.2 Abbvie Business Overview
        11.8.3 Abbvie Ocular Inflammation Treatment Introduction
        11.8.4 Abbvie Revenue in Ocular Inflammation Treatment Business (2017-2022)
        11.8.5 Abbvie Recent Development
    11.9 Eyegate Pharmaceuticals
        11.9.1 Eyegate Pharmaceuticals Company Detail
        11.9.2 Eyegate Pharmaceuticals Business Overview
        11.9.3 Eyegate Pharmaceuticals Ocular Inflammation Treatment Introduction
        11.9.4 Eyegate Pharmaceuticals Revenue in Ocular Inflammation Treatment Business (2017-2022)
        11.9.5 Eyegate Pharmaceuticals Recent Development
    11.10 pSivida
        11.10.1 pSivida Company Detail
        11.10.2 pSivida Business Overview
        11.10.3 pSivida Ocular Inflammation Treatment Introduction
        11.10.4 pSivida Revenue in Ocular Inflammation Treatment Business (2017-2022)
        11.10.5 pSivida Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Ocular Inflammation Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Immunosuppressant
    Table 3. Key Players of Monoclonal Antibodies
    Table 4. Key Players of Corticosteroids
    Table 5. Key Players of Cycloplegic Agents
    Table 6. Key Players of Antibiotics
    Table 7. Key Players of Analgesics
    Table 8. Key Players of Antivirals
    Table 9. Key Players of Antifungal
    Table 10. Global Ocular Inflammation Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 11. Global Ocular Inflammation Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 12. Global Ocular Inflammation Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 13. Global Ocular Inflammation Treatment Market Share by Region (2017-2022)
    Table 14. Global Ocular Inflammation Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 15. Global Ocular Inflammation Treatment Market Share by Region (2023-2028)
    Table 16. Ocular Inflammation Treatment Market Trends
    Table 17. Ocular Inflammation Treatment Market Drivers
    Table 18. Ocular Inflammation Treatment Market Challenges
    Table 19. Ocular Inflammation Treatment Market Restraints
    Table 20. Global Ocular Inflammation Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 21. Global Ocular Inflammation Treatment Market Share by Players (2017-2022)
    Table 22. Global Top Ocular Inflammation Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocular Inflammation Treatment as of 2021)
    Table 23. Ranking of Global Top Ocular Inflammation Treatment Companies by Revenue (US$ Million) in 2021
    Table 24. Global 5 Largest Players Market Share by Ocular Inflammation Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 25. Key Players Headquarters and Area Served
    Table 26. Key Players Ocular Inflammation Treatment Product Solution and Service
    Table 27. Date of Enter into Ocular Inflammation Treatment Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Ocular Inflammation Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 30. Global Ocular Inflammation Treatment Revenue Market Share by Type (2017-2022)
    Table 31. Global Ocular Inflammation Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 32. Global Ocular Inflammation Treatment Revenue Market Share by Type (2023-2028)
    Table 33. Global Ocular Inflammation Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 34. Global Ocular Inflammation Treatment Revenue Market Share by Application (2017-2022)
    Table 35. Global Ocular Inflammation Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 36. Global Ocular Inflammation Treatment Revenue Market Share by Application (2023-2028)
    Table 37. North America Ocular Inflammation Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Ocular Inflammation Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Ocular Inflammation Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Europe Ocular Inflammation Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Asia-Pacific Ocular Inflammation Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 42. Asia-Pacific Ocular Inflammation Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 43. Latin America Ocular Inflammation Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Latin America Ocular Inflammation Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Middle East & Africa Ocular Inflammation Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 46. Middle East & Africa Ocular Inflammation Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 47. Allergan Company Detail
    Table 48. Allergan Business Overview
    Table 49. Allergan Ocular Inflammation Treatment Product
    Table 50. Allergan Revenue in Ocular Inflammation Treatment Business (2017-2022) & (US$ Million)
    Table 51. Allergan Recent Development
    Table 52. Cipla Company Detail
    Table 53. Cipla Business Overview
    Table 54. Cipla Ocular Inflammation Treatment Product
    Table 55. Cipla Revenue in Ocular Inflammation Treatment Business (2017-2022) & (US$ Million)
    Table 56. Cipla Recent Development
    Table 57. Pfizer Company Detail
    Table 58. Pfizer Business Overview
    Table 59. Pfizer Ocular Inflammation Treatment Product
    Table 60. Pfizer Revenue in Ocular Inflammation Treatment Business (2017-2022) & (US$ Million)
    Table 61. Pfizer Recent Development
    Table 62. Novartis Company Detail
    Table 63. Novartis Business Overview
    Table 64. Novartis Ocular Inflammation Treatment Product
    Table 65. Novartis Revenue in Ocular Inflammation Treatment Business (2017-2022) & (US$ Million)
    Table 66. Novartis Recent Development
    Table 67. Valeant Pharmaceuticals International Company Detail
    Table 68. Valeant Pharmaceuticals International Business Overview
    Table 69. Valeant Pharmaceuticals International Ocular Inflammation Treatment Product
    Table 70. Valeant Pharmaceuticals International Revenue in Ocular Inflammation Treatment Business (2017-2022) & (US$ Million)
    Table 71. Valeant Pharmaceuticals International Recent Development
    Table 72. Alimera Sciences Company Detail
    Table 73. Alimera Sciences Business Overview
    Table 74. Alimera Sciences Ocular Inflammation Treatment Product
    Table 75. Alimera Sciences Revenue in Ocular Inflammation Treatment Business (2017-2022) & (US$ Million)
    Table 76. Alimera Sciences Recent Development
    Table 77. Akorn Company Detail
    Table 78. Akorn Business Overview
    Table 79. Akorn Ocular Inflammation Treatment Product
    Table 80. Akorn Revenue in Ocular Inflammation Treatment Business (2017-2022) & (US$ Million)
    Table 81. Akorn Recent Development
    Table 82. Abbvie Company Detail
    Table 83. Abbvie Business Overview
    Table 84. Abbvie Ocular Inflammation Treatment Product
    Table 85. Abbvie Revenue in Ocular Inflammation Treatment Business (2017-2022) & (US$ Million)
    Table 86. Abbvie Recent Development
    Table 87. Eyegate Pharmaceuticals Company Detail
    Table 88. Eyegate Pharmaceuticals Business Overview
    Table 89. Eyegate Pharmaceuticals Ocular Inflammation Treatment Product
    Table 90. Eyegate Pharmaceuticals Revenue in Ocular Inflammation Treatment Business (2017-2022) & (US$ Million)
    Table 91. Eyegate Pharmaceuticals Recent Development
    Table 92. pSivida Company Detail
    Table 93. pSivida Business Overview
    Table 94. pSivida Ocular Inflammation Treatment Product
    Table 95. pSivida Revenue in Ocular Inflammation Treatment Business (2017-2022) & (US$ Million)
    Table 96. pSivida Recent Development
    Table 97. Research Programs/Design for This Report
    Table 98. Key Data Information from Secondary Sources
    Table 99. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Ocular Inflammation Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Immunosuppressant Features
    Figure 3. Monoclonal Antibodies Features
    Figure 4. Corticosteroids Features
    Figure 5. Cycloplegic Agents Features
    Figure 6. Antibiotics Features
    Figure 7. Analgesics Features
    Figure 8. Antivirals Features
    Figure 9. Antifungal Features
    Figure 10. Global Ocular Inflammation Treatment Market Share by Application in 2021 & 2028
    Figure 11. Retail Pharmacies Case Studies
    Figure 12. Hospital Pharmacies Case Studies
    Figure 13. Online Pharmacies Case Studies
    Figure 14. Drug Stores Case Studies
    Figure 15. Ocular Inflammation Treatment Report Years Considered
    Figure 16. Global Ocular Inflammation Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 17. Global Ocular Inflammation Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 18. Global Ocular Inflammation Treatment Market Share by Region: 2021 VS 2028
    Figure 19. Global Ocular Inflammation Treatment Market Share by Players in 2021
    Figure 20. Global Top Ocular Inflammation Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocular Inflammation Treatment as of 2021)
    Figure 21. The Top 10 and 5 Players Market Share by Ocular Inflammation Treatment Revenue in 2021
    Figure 22. North America Ocular Inflammation Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. North America Ocular Inflammation Treatment Market Share by Country (2017-2028)
    Figure 24. United States Ocular Inflammation Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Canada Ocular Inflammation Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe Ocular Inflammation Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Europe Ocular Inflammation Treatment Market Share by Country (2017-2028)
    Figure 28. Germany Ocular Inflammation Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Ocular Inflammation Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Ocular Inflammation Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Ocular Inflammation Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Ocular Inflammation Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Ocular Inflammation Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Ocular Inflammation Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Ocular Inflammation Treatment Market Share by Region (2017-2028)
    Figure 36. China Ocular Inflammation Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Ocular Inflammation Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Ocular Inflammation Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Ocular Inflammation Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Ocular Inflammation Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Ocular Inflammation Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Latin America Ocular Inflammation Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Latin America Ocular Inflammation Treatment Market Share by Country (2017-2028)
    Figure 44. Mexico Ocular Inflammation Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Brazil Ocular Inflammation Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Middle East & Africa Ocular Inflammation Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Ocular Inflammation Treatment Market Share by Country (2017-2028)
    Figure 48. Turkey Ocular Inflammation Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Saudi Arabia Ocular Inflammation Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Allergan Revenue Growth Rate in Ocular Inflammation Treatment Business (2017-2022)
    Figure 51. Cipla Revenue Growth Rate in Ocular Inflammation Treatment Business (2017-2022)
    Figure 52. Pfizer Revenue Growth Rate in Ocular Inflammation Treatment Business (2017-2022)
    Figure 53. Novartis Revenue Growth Rate in Ocular Inflammation Treatment Business (2017-2022)
    Figure 54. Valeant Pharmaceuticals International Revenue Growth Rate in Ocular Inflammation Treatment Business (2017-2022)
    Figure 55. Alimera Sciences Revenue Growth Rate in Ocular Inflammation Treatment Business (2017-2022)
    Figure 56. Akorn Revenue Growth Rate in Ocular Inflammation Treatment Business (2017-2022)
    Figure 57. Abbvie Revenue Growth Rate in Ocular Inflammation Treatment Business (2017-2022)
    Figure 58. Eyegate Pharmaceuticals Revenue Growth Rate in Ocular Inflammation Treatment Business (2017-2022)
    Figure 59. pSivida Revenue Growth Rate in Ocular Inflammation Treatment Business (2017-2022)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Allergan
Cipla
Pfizer
Novartis
Valeant Pharmaceuticals International
Alimera Sciences
Akorn
Abbvie
Eyegate Pharmaceuticals
pSivida
Frequently Asked Questions
Ocular Inflammation Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Ocular Inflammation Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Ocular Inflammation Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Headliner (OE)

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More